PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Budesonide - Bronchopulmonary dysplasia
PAD Profile : Budesonide - Bronchopulmonary dysplasia
Brand Names Include :
Pulmicort
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
- Allergic rhinitis
- Inflammatory bowel disease
- Oesophagitis (inducing remission)
- Oesophagitis (maintenance)
- Covid-19
- Nephropathy
- Asthma
- Nasal polyps
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
03. Respiratory System
03.02.00. Corticosteroids (respiratory)